Propylamine

Propylamine

SCHEMBL8942462

CC(=O)Nc1cc(NS(C)(=O)=O)c(Oc2ccccc2)cc1[N+](=O)[O-].CCCN

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
KMT2A Q03164 3/20 0.53
MAPT P10636 3/20 0.53
LMNA P02545 3/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C9 P11712 2/20 0.53
MAPK1 P28482 2/20 0.53
MEN1 O00255 2/20 0.53
KDM4E B2RXH2 2/20 0.53
PTGS1 P23219 2/20 0.53
PTGS2 P35354 2/20 0.53
MLNR O43193 1/20 0.53
MMP1 P03956 1/20 0.53
MPO P05164 1/20 0.53
GLA P06280 1/20 0.53
CYP3A4 P08684 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
HPGD P15428 1/20 0.53
TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylamine SCHEMBL8942300 0.99 CYP19A1 (0.52) CYP19A1SMN1; SMN2KMT2AMAPTLMNA
Butylamine SCHEMBL8942510 0.95 MAPT (0.50) CYP19A1SMN1; SMN2KMT2AMAPTLMNA
Butylamine SCHEMBL8942543 0.94 MAPT (0.49) CYP19A1SMN1; SMN2KMT2AMAPTLMNA
SCHEMBL9574619 0.93 SMN1; SMN2 (0.60) CYP19A1SMN1; SMN2KMT2AMAPTLMNA
SCHEMBL8942347 0.87 MAPT (0.55) CYP19A1SMN1; SMN2KMT2AMAPTLMNA
Hydrochloric Acid SCHEMBL8942526 0.86 MAPT (0.54) CYP19A1SMN1; SMN2KMT2AMAPTLMNA
SCHEMBL9561587 0.85 SMN1; SMN2 (0.57) CYP19A1SMN1; SMN2KMT2AMAPTLMNA
SCHEMBL8942460 0.84 MAPT (0.56) CYP19A1SMN1; SMN2KMT2AMAPTLMNA
SCHEMBL8942456 0.84 SMN1; SMN2 (0.52) CYP19A1SMN1; SMN2KMT2AMAPTLMNA
Butylamine SCHEMBL8942217 0.84 TBXA2R (0.45) CYP19A1SMN1; SMN2KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5521311-A USEFUL AS ANTIINFLAMMATORY AGENTS, ANTIPYRETICS, ANALGESICS AND ANTI-ALLERGENIC AGENTS TAISHO PHARMACEUTICAL CO., LTD. (JP) 1996-05-28 US disclosed
EP-0685461-A1 5-AMINOACETYLAMINOSULFONANILIDE COMPOUND TAISHO PHARMACEUTICAL CO. LTD (JP) 1995-12-06 EP disclosed